Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab.

ABSTRACT:

Background

To report the first case of human herpesvirus-6 (HHV-6) corneal endotheliitis that developed after intravitreal ranibizumab injections.

Case presentation

A 63-year-old man with a medical history of diabetes and systemic steroid treatment for bullous pemphigoid had been receiving intravitreal injections of ranibizumab in the left eye for 2 years according to a Pro Re Nata treatment regimen for macular edema associated with branch retinal vein occlusion. Twenty days after the last injection, the patient presented with pain and decreased visual acuity in his left eye. His best corrected visual acuity in the left eye was 2/200, and intraocular pressure was 45 mmHg with edema of the central stromal cornea, mild conjunctival injection, intermediate keratic precipitates,

SUBMITTER: Onda M 

PROVIDER: S-EPMC6335734 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature